MedPath

Comparison of modified atkins diet and topiramate in children with refractory epileptic spasm.

Not Applicable
Conditions
Health Condition 1: - Health Condition 2: G408- Other epilepsy and recurrent seizures
Registration Number
CTRI/2023/08/056178
Lead Sponsor
ady hardinge medical college and Associated hospitals
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Diagnosis of infantile epileptic spasms syndrome as per the ILAE 2022 diagnostic criteria.

2)Failure of hormonal therapy, i.e. oral prednisolone or ACTH.

Exclusion Criteria

1)Known or suspected inborn error of metabolism

2)Prior use of the ketogenic or modified Atkins diet or Topiramate

3)Systemic illness- chronic hepatic, renal or pulmonary disease

4) Diagnosed renal stones

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The proportion of children with equal to or more than 50% reduction in clinical spasms at 12 weeks as compared to baseline as per parental reports in both groupsTimepoint: 12 weeks
Secondary Outcome Measures
NameTimeMethod
1) The proportion of children with clinical spasm cessation as per parental reports at the end of 12 weeks of treatment in both groups <br/ ><br>2) The proportion of children with equal & more than 1 point improvement in BASED score at 12 week as compared to baseline in both groups <br/ ><br>3) Adverse effects of the intervention in both groups <br/ ><br>4) Proportion of patients withdrawing from both the groups and reasons for withdrawal <br/ ><br>5) Proportion of patients with improvement in non-seizure domains like alertness, activity level, speech or communication, comprehension or understanding, sleeping, motor skills, social interaction and behaviour, as assessed by parental reports on Likert scale in both groupsTimepoint: 12 weeks
© Copyright 2025. All Rights Reserved by MedPath